AHL Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $3M | Sell |
27,422
-22,449
| -45% | -$2.46M | 0.05% | 612 |
|
|
2017
Q3 | $5.39M | Buy |
49,871
+28,061
| +129% | +$3.03M | 0.1% | 377 |
|
|
2017
Q2 | $2.21M | Buy |
21,810
+14,767
| +210% | +$1.49M | 0.05% | 593 |
|
|
2017
Q1 | $633K | Buy |
7,043
+2,771
| +65% | +$249K | 0.01% | 919 |
|
|
2016
Q4 | $326K | Sell |
4,272
-1,988
| -32% | -$152K | 0.01% | 948 |
|
|
2016
Q3 | $522K | Sell |
6,260
-1,047
| -14% | -$87.3K | 0.02% | 825 |
|
|
2016
Q2 | $602K | Buy |
7,307
+3,785
| +107% | +$312K | 0.03% | 568 |
|
|
2016
Q1 | $268K | Sell |
3,522
-28,006
| -89% | -$2.13M | 0.02% | 684 |
|
|
2015
Q4 | $2.54M | Buy |
31,528
+26,040
| +474% | +$2.09M | 0.2% | 194 |
|
|
2015
Q3 | $349K | Sell |
5,488
-65,664
| -92% | -$4.18M | 0.06% | 514 |
|
|
2015
Q2 | $5.01M | Buy |
71,152
+3,636
| +5% | +$256K | 0.2% | 177 |
|
|
2015
Q1 | $5.35M | Buy |
67,516
+25,209
| +60% | +$2M | 0.21% | 146 |
|
|
2014
Q4 | $2.69M | Buy |
42,307
+38,079
| +901% | +$2.42M | 0.14% | 296 |
|
|
2014
Q3 | $253K | Buy |
+4,228
| New | +$253K | 0.02% | 639 |
|